Many patients starting Zepbound (tirzepatide) for weight management expect consistent results, yet some experience plateaus or slower-than-anticipated progress
212,260,261 By interacting with receptors in the hypothalamus, GLP-1 influences satiety and reduces the consumption of food in both animals and humans
Canagliflozin Canagliflozin (Invokana) was approved for use in people with T2D by the EMA and the FDA in 2013
Both patient groups had higher scores on BDI-II than healthy controls, however
Tirzepatide Weight Loss Results The SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, provides the most direct head-to-head comparison
To get professional help with Tirzepatide treatment or managing emotional symptoms, contact our team today for a free consultation